Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia

NCT07750730 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Trigeminal Neuralgia (TN)

Interventions

PROCEDURE: Trigger Point Bloodletting Therapy
DRUG: Carbamazepine

Sponsor

Beijing Hospital of Traditional Chinese Medicine